Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
COMBINATION THERAPIES COMPRISING A QUINOXALINE INHIBITOR OF PI3K-ALPHA FOR USE IN THE TREATMENT OF CANCER
No-Receipt date
2013-03928 - 17/12/2013
No-Filing date
20130402680 - 17/12/2013
No-Granting date
3082404 - 23/12/2013
No-EPO application date
08742674.8 - 08/04/2008
No-EPO granting date
2139483 - 18/09/2013
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
12/2013 - 24/01/2014
Expiration date
09/04/2028
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US923164 P11/04/2007/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/337
A61K 31/436
A61K 31/497
A61K 31/498
A61K 31/4985
A61K 31/517
A61K 31/555
A61K 45/06
A61P 35/00
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
505115
EXELIXIS, INC.
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1210171
LAMB, PETER
1210172
MATTHEWS, DAVID
Representatives
Code
Firstname
Surname
Address
Town
Zip
3254
MARIA
PAPANIKOLAOU
PONTOU 30
PEFKI (ATTIKIS)
15121
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2897
ALKISTIS-EIRINI
MALAMI
SKOUFA 52
ATHINA (ATTIKIS)
10672
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
11/8/2021 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 10 / 2021 - Αρ. Πρωτ. ΓΔ 2013 / 08.11.2021
Payments history
13 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).